Contract
Posted on 2/21/2026
Develops spine and orthopedic reconstructive devices
$19 - $25/hr
Lewisville, TX, USA
In Person
Orthofix Medical Inc. focuses on reconstructive and regenerative orthopedic and spine solutions for surgeons and hospitals. It operates in two groups: Global Spine, which offers spinal fusion products such as bone growth stimulators, spinal implants, and biologics, and Global Orthopedics, which provides devices for fracture fixation, deformity correction, and bone reconstruction. The company’s products are used to treat musculoskeletal conditions like degenerative disc disease, spinal stenosis, and fractures, and are sold through a direct sales force and a network of independent distributors in the U.S. and internationally. Orthofix grows by developing and commercializing new products and by acquiring complementary technologies and businesses, expanding its portfolio and market reach. Its goal is to improve musculoskeletal health by delivering a broad range of surgical solutions for spine and orthopedic care.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Lewisville, Texas
Founded
1980
Help us improve and share your feedback! Did you find this helpful?
Performance Bonus
Orthofix Medical has restructured its Spine leadership team to accelerate growth and execution, with key leaders now reporting directly to CEO Massimo Calafiore. The company eliminated the President, Global Spine Solutions role, whilst Shaeffer Bannigan assumes expanded responsibilities for Spine strategy and commercial operations. The medical technology company reported preliminary first quarter 2026 net sales of approximately $196.7 million, representing a 0.4% increase on a reported basis and 3% growth on a non-GAAP pro forma constant currency basis compared to Q1 2025. Non-GAAP pro forma net sales, excluding M6 disc sales, totalled approximately $196.4 million. The reorganisation aims to streamline decision-making and strengthen focus on the 7D navigation platform commercialisation. Patrick Fisher has also expanded his remit to include Biologics alongside Limb Reconstruction.
Xtant Medical launches OsteoFactor Pro A groundbreaking growth factor solution to advance bone healing.
Orthofix announces Appointment of Vickie Capps to Board of Directors.
LOS ANGELES, Feb. 26, 2025 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) is set to make a powerful comeback. On March 1st, it will host its 22nd Annual Gathering for the Cure (GFC) award gala at the Millennium Biltmore Hotel in Los Angeles. The red carpet will take place from 6:00 to 8:00 p.m., followed by the award banquet from 8:00 to 11:00 p.m
Monday, March 10, 2025 at 9:00 am Pacific TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT.Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com.Internet Posting of InformationOrthofix routinely posts information that may be important to investors in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.About OrthofixOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system